<SEC-DOCUMENT>0001021771-23-000112-index.html : 20231115
<SEC-HEADER>0001021771-23-000112.hdr.sgml : 20231115
<ACCEPTANCE-DATETIME>20231115161435
ACCESSION NUMBER:		0001021771-23-000112
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20231115
DATE AS OF CHANGE:		20231115
EFFECTIVENESS DATE:		20231115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioRestorative Therapies, Inc.
		CENTRAL INDEX KEY:			0001505497
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				911835664
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275571
		FILM NUMBER:		231410730

	BUSINESS ADDRESS:	
		STREET 1:		40 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		(631) 760-8100

	MAIL ADDRESS:	
		STREET 1:		40 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stem Cell Assurance, Inc.
		DATE OF NAME CHANGE:	20101110
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>brts8.htm
<DESCRIPTION>REGISTRATION OF ADDITIONAL 1,350,000 UNDER 2021 STOCK INCENTIVE PLAN
<TEXT>
Document 1 - file: brts8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>2
<FILENAME>ex5.htm
<DESCRIPTION>OPINION OF COUNSEL
<TEXT>
Document 2 - file: ex5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex23_1.htm
<DESCRIPTION>CONSENT OF FRIEDMAN LLP
<TEXT>
Document 3 - file: ex23_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ex23_2.htm
<DESCRIPTION>CONSENT OF MARCUM LLP
<TEXT>
Document 4 - file: ex23_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ex107.htm
<DESCRIPTION>FILING FEES TABLE
<TEXT>
Document 5 - file: ex107.htm

</DOCUMENT>
</SEC-DOCUMENT>